Exosome RNA Exosome RNA Research & Industry News
Turn Biotechnologies has acquired ARMMs technology, a novel extracellular vesicle-based platform that enables precise, non-viral delivery of gene editors, proteins, and RNA therapies. By integrating ARMMs with its eTurna™ LNP system, the company expands its ability to safely and effectively target a broad range of tissues for regenerative and immune...
Read More »Turn Biotechnologies Acquires ARMMs Vesicular Technology to Increase Access to Tissue Targets for Its Epigenetic Reprogramming Therapies
